Sun, Dec 21, 2014, 5:11 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ACADIA Pharmaceuticals Inc. Message Board

  • redstenox redstenox Dec 1, 2012 6:12 PM Flag

    ►► ACAD (exceptional review) ◄◄

    Friday a High Wave was formed. This implies a loss of sense of direction and that there is a great amount of indecision in the market. Bears are seemingly fatigued after consolidation and a bullish pattern seems to be forming. 60 million volume surges typically have reason and follow later "Large gains" bears would be well advised to buy to cover and go long or sit this one out.

    ACAD's pimavanserin drug = first true Parkinson's disease psychosis treatment. The market will rapidly change towards a more bullish perspective on ACAD due to the recent results, which prove that the drug actually works! The drug is the company's most advanced and if approved currently has no competition in the marketplace. Those who were treated with pimavanserin, a 5.79-point reduction in psychotic behavior was observed, compared to a 2.73-point reduction in the control group. These results are statistically significant!

    Acadia's run looks to be well deserved and will continue.

    This review establishes an opinion of: MARKET OUTPERFORM price target $30 for those with patience.

    Investors will probably agree with this review using their due diligence/fact checking.

    Respectfully,
    Redstenox

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACAD
32.98+0.13(+0.41%)Dec 19 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.